Working with our dental partners Pro3dure Medical, our anti biofilm platform (Remora™) has been incorporated into two of their key medical devices using their MSI® (Multi Species Inhibition) technology. We…
Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials...
Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials...
Penrhos Bio is currently undertaking a Series A investment raise. This investment will accelerate our regulatory roadmap for the Remora™ technology and unlocks a number of higher value markets such as marine fouling and human healthcare...
Penrhos Bio joins with Pro3dure™ in a milestone licence deal that will bring the Remora™ technology into the dental space in 3D printed materials...
Thanks to our Partners in Earthbound Brands, Remora™ becomes our brand name, logo and the face of Penrhos Bio. Supported by the ‘Cleaner by Nature’ tagline, the new Remora name will flow though onto products in our customers hands...
Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology and is joined as an investment partner by Eos Advisory...
Penrhos Bio has become a member of the National Biofilms Innovation Centre, a world leading Innovation Knowledge Centre connecting scientists and industrial partners specialising in Biofilms from across the UK...
Dental plaque is an example of a typical biofilm composed of a complex microbial community. Plaque is the contributing agent for major dental diseases such as dental caries and periodontal disease...
We are very pleased that Dr Yvonne Davies and Professor Richard Hammond have joined Penrhos Bio full time. Yvonne is Head of Business development and Richard is CEO...